journal article·2020-05

Effects of different polyaniline emeraldine compositions in electrodepositing ginsenoside encapsulated poly(lactic‐co‐glycolic acid) microcapsules coating: Physicochemical characterization and in vitro evaluation

Siti Khadijah Lukman, Syafiqah Saidin

Publisher page

Abstract

Abstract Even though drug‐eluting stent (DES) has prominently reduced restenosis, however, its complication of delayed endothelialization has caused chronic side effect. A coating of ginseng‐based biodegradable polymer could address this issue due to its specific therapeutic values. However, deposition of this type of stable coating on metallic implant often scarce. Therefore, in this study, different polyaniline (PANI) emeraldine compositions were adopted to electrodeposit ginsenoside encapsulated poly(lactic‐co‐glycolic acid) microcapsules coating. The coating surfaces were analyzed using attenuated total reflectance‐Fourier transform infrared spectroscopy, X‐ray photoelectron spectroscopy, scanning electron microscopy, contact angle, and atomic force microscopy instruments. A month coating stability was then investigated with an evaluation of in vitro human umbilical vein endothelial cell analyses consisted of cytotoxicity and cells attachment assessments. The 1.5 mg PANI emeraldine has assisted the formation of stable, uniform, and rounded microcapsules coating with appropriate wettability and roughness. Less than 1.5 mg PANI emeraldine was not enough to drive the formation of microcapsules coating while greater than 1.5 mg caused the deposition of melted microcapsules. The similar coating also has promoted greater cells proliferation and attachment compared to other coating variation. Therefore, the utilization of electrodeposition to deposit a drug‐based polymer coating could be implemented to develop DES, in accordance to stent implantation which ultimately aims for enrich endothelialization.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Coronary Interventions and Diagnostics · Ginseng Biological Effects and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Biomedical Engineering and Health Sciences, Faculty of Engineering Universiti Teknologi Malaysia Johor Bahru Johor Malaysia

IJN‐UTM Cardiovascular Engineering Centre, Institute of Human Centered Engineering Universiti Teknologi Malaysia Johor Bahru Johor Malaysia

References (70)

Show source-provided references
1. 10.1186/2193-1801-2-9610.1186/2193-1801-2-96 ↗
2. 10.1186/2055-7124-18-1710.1186/2055-7124-18-17 ↗
3. 10.1016/j.actbio.2014.02.01510.1016/j.actbio.2014.02.015 ↗
4. 10.1016/j.arabjc.2015.04.01710.1016/j.arabjc.2015.04.017 ↗
5. 10.3390/coatings203009510.3390/coatings2030095 ↗
6. 10.1016/j.actbio.2013.10.01510.1016/j.actbio.2013.10.015 ↗
7. 10.1016/j.phpro.2012.12.00310.1016/j.phpro.2012.12.003 ↗
8. Preparation and properties study of polyaniline conductive anti‐fouling coatings10.1016/S1452-3981(23)17984-3 ↗
9. 10.1111/jcmm.1393610.1111/jcmm.13936 ↗
10. Court W. E. · 2000 · 200310.1201/9780203304518 ↗
11. Electrochemical functionalization of a 316L stainless steel surface with a 11‐mercaptoundecanoic acid monolayer: Stability studies10.1016/S1452-3981(23)14027-2 ↗
12. 10.1073/pnas.100859510710.1073/pnas.1008595107 ↗
13. 10.1007/8415_2010_5410.1007/8415_2010_54 ↗
14. 10.4236/jbnb.2012.3202710.4236/jbnb.2012.32027 ↗
15. 10.1007/s13556-013-0005-710.1007/s13556-013-0005-7 ↗
16. 10.3390/ijms1503364010.3390/ijms15033640 ↗
17. 10.1007/s10856-006-9228-410.1007/s10856-006-9228-4 ↗
18. 10.1097/FJC.0b013e3180cab12e10.1097/FJC.0b013e3180cab12e ↗
19. 10.1161/CIRCRESAHA.115.30761110.1161/CIRCRESAHA.115.307611 ↗
20. 10.3390/ma303151510.3390/ma3031515 ↗
21. 10.1039/b107499g10.1039/b107499g ↗
22. 10.1016/j.colsurfb.2014.11.02810.1016/j.colsurfb.2014.11.028 ↗
23. 10.1007/s10544-011-9583-x10.1007/s10544-011-9583-x ↗
24. 10.1016/j.yjmcc.2016.12.00510.1016/j.yjmcc.2016.12.005 ↗
25. 10.3390/ma702076910.3390/ma7020769 ↗
26. 10.1080/09205063.2016.123994710.1080/09205063.2016.1239947 ↗
27. 10.3746/pnf.2016.21.4.38910.3746/pnf.2016.21.4.389 ↗
28. 10.5142/jgr.2012.36.1.110.5142/jgr.2012.36.1.1 ↗
29. 10.1371/journal.pone.006127110.1371/journal.pone.0061271 ↗
30. 10.1016/j.synthmet.2009.02.03610.1016/j.synthmet.2009.02.036 ↗
31. 10.1016/j.jgr.2016.08.00410.1016/j.jgr.2016.08.004 ↗
32. 10.1006/jcis.2001.795410.1006/jcis.2001.7954 ↗
33. 10.1016/j.vetimm.2014.08.01010.1016/j.vetimm.2014.08.010 ↗
34. 10.1186/s40824-018-0114-110.1186/s40824-018-0114-1 ↗
35. 10.1016/j.apsusc.2009.12.04610.1016/j.apsusc.2009.12.046 ↗
36. 10.3390/jfb502004310.3390/jfb5020043 ↗
37. Accelerated recovery of endothelium function after stent implantation with the use of a novel systemic nanoparticle curcumin10.1155/2015/291871 ↗
38. 10.11113/mjfas.v15n2.111510.11113/mjfas.v15n2.1115 ↗
39. 10.1248/cpb.c18-0084710.1248/cpb.c18-00847 ↗
40. 10.1161/CIRCULATIONAHA.106.67593410.1161/CIRCULATIONAHA.106.675934 ↗
41. 10.1039/c4ra00083h10.1039/c4ra00083h ↗
42. 10.3390/polym303137710.3390/polym3031377 ↗
43. 10.1039/C1JM13726C10.1039/C1JM13726C ↗
44. 10.1016/j.mseb.2007.07.08910.1016/j.mseb.2007.07.089 ↗
45. Ginsenosides as anticancer agents: in‐vitro and in‐vivo activities, structure‐activity relationships and molecular mechanisms of action
46. 10.4103/2045-080X.18303010.4103/2045-080X.183030 ↗
47. 10.1016/j.corsci.2008.04.00510.1016/j.corsci.2008.04.005 ↗
48. 10.1016/j.jgr.2014.05.01110.1016/j.jgr.2014.05.011 ↗
49. 10.3390/1001014610.3390/10010146 ↗
50. 10.1016/j.colsurfb.2011.03.03310.1016/j.colsurfb.2011.03.033 ↗
51. 10.1016/j.ijpharm.2012.10.02910.1016/j.ijpharm.2012.10.029 ↗
52. 10.1016/j.jgr.2015.09.00510.1016/j.jgr.2015.09.005 ↗
53. 10.1142/S0192415X1450039610.1142/S0192415X14500396 ↗
54. 10.1016/j.bsbt.2015.08.00110.1016/j.bsbt.2015.08.001 ↗
55. 10.1039/b902881a10.1039/b902881a ↗
56. 10.5142/jgr.2013.37.6410.5142/jgr.2013.37.64 ↗
57. 10.1016/j.jgr.2016.08.01110.1016/j.jgr.2016.08.011 ↗
58. Green synthesis of silver nanoparticles using Panax ginseng root extract for the detection of Hg 2+
59. 10.1016/j.jbiotec.2013.01.02010.1016/j.jbiotec.2013.01.020 ↗
60. Enhanced in‐vitro angiogenic behaviour of human umbilical vein endothelial cells on thermally oxidized TiO2 nanofibrous surfaces
61. Polyaniline‐polypyrrole coating for solid phase microextraction
62. 10.1016/j.jep.2010.05.02710.1016/j.jep.2010.05.027 ↗
63. 10.1016/j.msec.2015.04.03110.1016/j.msec.2015.04.031 ↗
64. 10.1016/j.msec.2017.05.11510.1016/j.msec.2017.05.115 ↗
65. 10.1016/j.surfcoat.2014.09.03110.1016/j.surfcoat.2014.09.031 ↗
66. 10.3390/polym911059810.3390/polym9110598 ↗
67. 10.1016/j.colsurfb.2018.01.00210.1016/j.colsurfb.2018.01.002 ↗
68. Attenuation of TNF‐α‐induced inflammatory injury in endothelial cells by ginsenoside Rb1 via inhibiting NF‐κB, JNK and p38 signaling pathways
69. 10.1016/j.thromres.2013.10.03210.1016/j.thromres.2013.10.032 ↗
70. 10.1002/jcb.2223310.1002/jcb.22233 ↗